FI61701C - Foerfarande foer framstaellning av h2-histaminantagonistiska 2-amino-4-pyrimidonderivat - Google Patents

Foerfarande foer framstaellning av h2-histaminantagonistiska 2-amino-4-pyrimidonderivat Download PDF

Info

Publication number
FI61701C
FI61701C FI762803A FI762803A FI61701C FI 61701 C FI61701 C FI 61701C FI 762803 A FI762803 A FI 762803A FI 762803 A FI762803 A FI 762803A FI 61701 C FI61701 C FI 61701C
Authority
FI
Finland
Prior art keywords
pyrimidone
methyl
ethanol
imidazolylmethylthio
methylthio
Prior art date
Application number
FI762803A
Other languages
English (en)
Finnish (fi)
Other versions
FI762803A (ko
FI61701B (fi
Inventor
Thomas Henry Brown
Graham John Durant
John Colin Emmett
Charon Robin Ganellin
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of FI762803A publication Critical patent/FI762803A/fi
Publication of FI61701B publication Critical patent/FI61701B/fi
Application granted granted Critical
Publication of FI61701C publication Critical patent/FI61701C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI762803A 1975-10-02 1976-10-01 Foerfarande foer framstaellning av h2-histaminantagonistiska 2-amino-4-pyrimidonderivat FI61701C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4034175 1975-10-02
GB4034175 1975-10-02

Publications (3)

Publication Number Publication Date
FI762803A FI762803A (ko) 1977-04-03
FI61701B FI61701B (fi) 1982-05-31
FI61701C true FI61701C (fi) 1982-09-10

Family

ID=10414412

Family Applications (1)

Application Number Title Priority Date Filing Date
FI762803A FI61701C (fi) 1975-10-02 1976-10-01 Foerfarande foer framstaellning av h2-histaminantagonistiska 2-amino-4-pyrimidonderivat

Country Status (36)

Country Link
JP (2) JPS5246087A (ko)
AR (1) AR221682A1 (ko)
AT (1) AT358045B (ko)
AU (1) AU504897B2 (ko)
BE (1) BE846452A (ko)
BG (1) BG25224A3 (ko)
CA (1) CA1067076A (ko)
CH (1) CH625801A5 (ko)
CS (1) CS203003B2 (ko)
DD (1) DD126563A5 (ko)
DE (1) DE2643670C2 (ko)
DK (1) DK442476A (ko)
ES (1) ES452060A1 (ko)
FI (1) FI61701C (ko)
FR (1) FR2326192A1 (ko)
GR (1) GR61307B (ko)
HU (1) HU175537B (ko)
IE (1) IE44845B1 (ko)
IL (1) IL50503A (ko)
IN (1) IN146736B (ko)
IT (2) IT1070839B (ko)
LU (1) LU75922A1 (ko)
MW (1) MW3476A1 (ko)
MX (1) MX4614E (ko)
NL (1) NL7609917A (ko)
NO (1) NO145792C (ko)
NZ (1) NZ181959A (ko)
OA (1) OA05445A (ko)
PH (1) PH13921A (ko)
PL (1) PL105828B1 (ko)
PT (1) PT65590B (ko)
RO (1) RO73511A (ko)
SE (1) SE431872B (ko)
YU (1) YU237276A (ko)
ZA (1) ZA765498B (ko)
ZM (1) ZM12176A1 (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
NZ186511A (en) 1977-03-19 1980-11-14 Smith Kline French Lab 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones
NZ186965A (en) 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
JPS54104816A (en) * 1978-01-27 1979-08-17 Memorex Corp Magnetic recorder tape reel
IN151188B (ko) * 1978-02-13 1983-03-05 Smith Kline French Lab
AU527202B2 (en) * 1978-04-11 1983-02-24 Smith Kline & French Laboratories Limited 2-aminopyrimidones
IL57416A (en) * 1978-05-30 1983-03-31 Smith Kline French Lab Nitro compounds,processes for preparing them and compositions containing them
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
US4374836A (en) 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
JPS55145683A (en) * 1979-04-26 1980-11-13 Smith Kline French Lab Pyrimidone derivative
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them
CA1206151A (en) * 1981-12-28 1986-06-17 Richard P. Pioch Pyrimidone anti-ulcer agents
JPS5993074A (ja) * 1982-10-01 1984-05-29 スミス・クライン・アンド・フレンチ・ラボラトリ−ス・リミテツド ピリミドン誘導体
DE8309239U1 (de) * 1983-03-29 1983-09-29 Basf Ag, 6700 Ludwigshafen Bandspule, insbesondere fuer magnetbaender

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them

Also Published As

Publication number Publication date
FI762803A (ko) 1977-04-03
YU237276A (en) 1983-01-21
FR2326192B1 (ko) 1979-01-12
MW3476A1 (en) 1977-11-09
IN146736B (ko) 1979-08-25
DE2643670C2 (de) 1982-07-01
BG25224A3 (en) 1978-08-10
NZ181959A (en) 1978-07-28
ATA711976A (de) 1980-01-15
MX4614E (es) 1982-07-07
PL105828B1 (pl) 1979-11-30
OA05445A (fr) 1981-03-31
DK442476A (da) 1977-04-03
AT358045B (de) 1980-08-11
AU1829576A (en) 1978-04-06
IE44845L (en) 1977-04-02
CH625801A5 (en) 1981-10-15
JPS5635674B2 (ko) 1981-08-19
ES452060A1 (es) 1977-10-01
PT65590B (en) 1978-03-28
LU75922A1 (ko) 1977-05-06
IL50503A0 (en) 1976-11-30
GR61307B (en) 1978-10-19
PH13921A (en) 1980-11-04
CS203003B2 (en) 1981-02-27
BE846452A (fr) 1977-03-22
DE2643670A1 (de) 1977-04-14
NO145792B (no) 1982-02-22
ZA765498B (en) 1977-08-31
RO73511A (ro) 1981-04-30
IL50503A (en) 1980-12-31
IT1070839B (it) 1985-04-02
ZM12176A1 (en) 1977-07-21
AR221682A1 (es) 1981-03-13
CA1067076A (en) 1979-11-27
FI61701B (fi) 1982-05-31
PT65590A (en) 1976-10-01
NO145792C (no) 1982-06-02
IE44845B1 (en) 1982-04-21
NO763371L (ko) 1977-04-05
JPS5246087A (en) 1977-04-12
IT7830708A0 (it) 1978-12-11
JPS609755B2 (ja) 1985-03-12
NL7609917A (nl) 1977-04-05
AU504897B2 (en) 1979-11-01
SE7610409L (sv) 1977-04-03
DD126563A5 (ko) 1977-07-27
HU175537B (hu) 1980-08-28
SE431872B (sv) 1984-03-05
JPS5695186A (en) 1981-08-01
FR2326192A1 (fr) 1977-04-29

Similar Documents

Publication Publication Date Title
FI61701C (fi) Foerfarande foer framstaellning av h2-histaminantagonistiska 2-amino-4-pyrimidonderivat
US4208521A (en) Process for the preparation of imidazo[2,1-b]quinazolinones
DE69624010T2 (de) Sulfonamide Derivate und Verfahren zu deren Herstellung
DE69600221T2 (de) Naphthalinderivate, ihre Herstellungsverfahren und Zwischenprodukte dafür, und diese enthaltende pharmazeutische Zusammensetzungen
CZ99693A3 (en) Amino quinolone derivatives substituted by aryl or aromatic heterocyclic groups
FI62668C (fi) Foerfarande foer framstaellning av h1- och h2-histaminantagonistiska 2-amino-4-pyrimidonderivat
EP0019811A1 (de) Pyrimidin-Verbindungen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung
DE69713255T2 (de) Pharmazeutische Pyridin-Derivate, ihre Herstellungsverfahren und Zwischenprodukte dafür
SU944504A3 (ru) Способ получени производных 2-аминопиримидона
JPH0517470A (ja) ピラゾール誘導体
US4227000A (en) Intermediates in the process for making histamine antagonists
US4436913A (en) 1H- and 2H- indazole derivatives
DE2165056A1 (de) Verfahren zur Herstellung von Chinazolinonen
AU683569B2 (en) Trifluoromethylquinolinecarboxylic acid derivative
SU627752A3 (ru) Способ получени стереооднородных цис- или транс-5,6-алкилен-5,6-дигидропиримидин-4(3н)онов
Saggu et al. Benzimidazoles withbiphenyls: Synthesis of 5-substituted-2-n-propyl-1-[(2'-carboxybiphenyl-4-yl-) methyl] benzimidazoles
EP0796251B1 (de) Uracilderivate
DE69928610T2 (de) Verfahren zur Herstellung von 2-Carbamoyl-Pyridinen
DE1935671B2 (de) 2-Aminomethylindole und ihre Salze
US3591589A (en) 6-dialkylaminoalkoxy - 2-aryl-4-chloropyrimidines and 6-dialkylaminoalkylthio-2-aryl-4-chloropyrimidines
DE2162327B2 (de) Verfahren zur Herstellung von 3,4 Dihydro-2(1 H)-chlnazolinonen
CA1133481A (en) Process for making histamine antagonists
SU504492A3 (ru) Способ получени производных 5,6,7,8-тетрагидропиридо-(4",3:4,5)-тиено-(2,3-д)-пиримидина
JPS6241231B2 (ko)
SU332630A1 (ko)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SMITH KLINE & FRENCH LABORATORIES